Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robin Kramer currently holds 25,640 shares of BIOGEN INC. (BIIB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robin Kramer has been a net seller of BIIB stock. They have purchased $0 and sold $183.1K worth of shares.
Robin Kramer's most recent insider trade was on Mar 9, 2026, when they sold 25,640 shares at $0.00 per share.
Robin Kramer serves as Executive at BIOGEN INC. (BIIB). They have executed 72 insider transactions totaling $183.1K over their tenure at the company.
Robin Kramer holds the position of Executive at BIOGEN INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Robin Kramer has shown a selling trading pattern, with $0 in total purchases and $183.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robin Kramer was on Jul 1, 2021, when they sold $87.6K worth of BIIB shares. This transaction involved 251 shares at $348.92 per share.
Robin Kramer currently owns 25,640 shares of BIOGEN INC. (BIIB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robin Kramer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robin Kramer has 72 Form 4 filings on record as an insider at BIOGEN INC..
Set alerts for Robin Kramer and 40,000+ other insiders.